Showing results (281-290 of 319) with videos related to

Sort By:
Pageof 32
Pharmacogenetics and Genomics|October 19, 2006
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group studyAlison A Motsinger, Marylyn D Ritchie, Robert W Shafer, et al.
The Journal of Infectious Diseases|November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group StudyDavid W Haas, Laura M Smeaton, Robert W Shafer, et al.
Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2022
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
The New England Journal of Medicine|December 12, 2003
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infectionGregory K Robbins, Victor De Gruttola, Robert W Shafer, et al.
The New England Journal of Medicine|December 12, 2003
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infectionRobert W Shafer, Laura M Smeaton, Gregory K Robbins, et al.
Pageof 32